[1]
S. R. Quist, “Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno-globulin E”, Acta Derm Venereol, vol. 93, no. 2, pp. 206–208, Oct. 2012.